122 related articles for article (PubMed ID: 12599245)
21. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
Layland MK; Sessions DG; Lenox J
Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
[TBL] [Abstract][Full Text] [Related]
22. A spontaneous squamous cell carcinoma of the oral cavity in a squirrel monkey (Saimiri sciureus).
Sasseville VG; Pauley DR; Spaulding GL; Chalifoux LV; Lee-Parritz D; Simon MA
J Med Primatol; 1993 Jun; 22(4):272-5. PubMed ID: 7693948
[TBL] [Abstract][Full Text] [Related]
23. Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion?
Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; See LC; Yen TC
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):371-6. PubMed ID: 18474310
[TBL] [Abstract][Full Text] [Related]
24. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation.
Harada K; Supriatno ; Kawaguchi S; Kawashima Y; Itashiki Y; Yoshida H; Sato M
Anticancer Res; 2005; 25(3c):2471-5. PubMed ID: 16080478
[TBL] [Abstract][Full Text] [Related]
25. Oral histoplasmosis after radiation therapy for laryngeal squamous cell carcinoma.
Ezzedine K; Accoceberry I; Malvy D
J Am Acad Dermatol; 2007 May; 56(5):871-3. PubMed ID: 17113188
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
27. Multiple basal cell carcinoma developing two years after 60Co irradiation.
Iwamoto I; Endo M; Kakinuma H; Suzuki H
Eur J Dermatol; 1998; 8(3):180-2. PubMed ID: 9649688
[TBL] [Abstract][Full Text] [Related]
28. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Rosenquist K
Swed Dent J Suppl; 2005; (179):1-66. PubMed ID: 16335030
[TBL] [Abstract][Full Text] [Related]
29. Ki-67 expression in cytologic scrapes from oral squamous cell carcinoma before and after 24 gray radiotherapy--a study on 43 patients.
Sharma P; Kumar N; Bahadur AK; Mandal AK
Med Oral Patol Oral Cir Bucal; 2005 Apr; 10 Suppl 1():E15-7. PubMed ID: 15800463
[TBL] [Abstract][Full Text] [Related]
30. Radiation-induced leiomyosarcoma of oral cavity: Two cases with a review of literature.
Sagar N; Singh M; Goyal N; Khurana N; Singh K; Meher R
J Cancer Res Ther; 2020 Dec; 16(Supplement):S230-S232. PubMed ID: 33380685
[TBL] [Abstract][Full Text] [Related]
31. Oral squamous cell carcinoma: a clinicopathologic review of 233 cases in Lagos, Nigeria.
Effiom OA; Adeyemo WL; Omitola OG; Ajayi OF; Emmanuel MM; Gbotolorun OM
J Oral Maxillofac Surg; 2008 Aug; 66(8):1595-9. PubMed ID: 18634945
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
Tímár J; Ladányi A; Forster-Horváth C; Lukits J; Döme B; Remenár E; Godény M; Kásler M; Bencsik B; Répássy G; Szabó G; Velich N; Suba Z; Elo J; Balatoni Z; Pócza K; Zemplén B; Chretien P; Talor E
J Clin Oncol; 2005 May; 23(15):3421-32. PubMed ID: 15908653
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant and adjuvant therapy in patients with oral squamous cell carcinoma Long-term survival in a prospective, non-randomized study.
Kessler P; Grabenbauer G; Leher A; Bloch-Birkholz A; Vairaktaris E; Neukam FW
Br J Oral Maxillofac Surg; 2008 Jan; 46(1):1-5. PubMed ID: 17931758
[TBL] [Abstract][Full Text] [Related]
34. Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. I. The case of T1N0 disease.
Cellai E; Frata P; Magrini SM; Paiar F; Barca R; Fondelli S; Polli C; Livi L; Bonetti B; Vitali E; De Stefani A; Buglione M; Biti G
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1378-86. PubMed ID: 16095847
[TBL] [Abstract][Full Text] [Related]
35. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity.
Koo BS; Lim YC; Lee JS; Choi EC
Oral Oncol; 2006 Sep; 42(8):789-94. PubMed ID: 16455287
[TBL] [Abstract][Full Text] [Related]
36. Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma.
Szelachowska J; Dziegiel P; Jelen-Krzeszewska J; Jelen M; Matkowski R; Pomiecko A; Spytkowska B; Jagas M; Gisterek I; Kornafel J
Anticancer Res; 2006; 26(3B):2473-8. PubMed ID: 16821635
[TBL] [Abstract][Full Text] [Related]
37. The prognostic significance of histological features in oral squamous cell carcinoma.
Larsen SR; Johansen J; Sørensen JA; Krogdahl A
J Oral Pathol Med; 2009 Sep; 38(8):657-62. PubMed ID: 19563504
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic characteristics of head and neck squamous cell carcinoma in Puerto Ricans.
Busquets JM; García HA; Trinidad-Pinedo J; Baez A
P R Health Sci J; 2003 Sep; 22(3):259-64. PubMed ID: 14619452
[TBL] [Abstract][Full Text] [Related]
39. Radiation-related cytological changes in oral malignant cells.
Mehrotra R; Goel N; Singh M; Kumar D
Indian J Pathol Microbiol; 2004 Jul; 47(3):343-7. PubMed ID: 16295420
[TBL] [Abstract][Full Text] [Related]
40. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
